Vor Biopharma Inc. (VOR) Financials

VOR Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 506.7 million 657.2 million
Dec. 31, 2025 464.1 million 628.4 million
Sept. 30, 2025 176.2 million 2.4 billion
June 30, 2025 205.4 million 1.7 billion

VOR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -38.3 million 8.9 million
Dec. 31, 2025 -23.1 million 9.0 million
Sept. 30, 2025 -53.9 million 8.0 million
June 30, 2025 -35.3 million 1.8 million

VOR Net Income

No data available :(

VOR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 491.5 million 2.6 million -
Dec. 31, 2025 455.2 million - 2.7 million
Sept. 30, 2025 170.5 million - 2.8 million
June 30, 2025 203.0 million - -

VOR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 430115
Dec. 31, 2025 9.9 million
Sept. 30, 2025 6.7 million
June 30, 2025 6.3 million

VOR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 48000 17.6 million 17.5 million -
Dec. 31, 2025 314000 19.2 million 16.8 million -
Sept. 30, 2025 244000 14.1 million 14.4 million -
June 30, 2025 152000 261.5 million 2.4 million -

VOR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 28000
Dec. 31, 2025 - 23000
Sept. 30, 2025 - -
June 30, 2025 - 2.1 million

VOR

Price: $14.49

52 week price:
3.62
65.80

Earnings Per Share: -70.40 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 63919

Market Capitalization: 91.1 million

Links: